Yahoo
    Copenhagen - Delayed Quote DKK

    ALK-Abelló A/S (ALK-B.CO)

    248.00 +1.40 (+0.57%)
    At close: October 30 at 4:59:30 PM GMT+1
    Loading Chart for ALK-B.CO
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    Will Raised 2026 Guidance Change ALK Abelló Stock Narrative

    Will Raised 2026 Guidance Change ALK Abelló Stock Narrative
    Simply Wall St. 15d ago
    ALK-Abelló Pharmaceuticals Inc Announces Positive Funding Recommendation from Canada's Drug Agency for neffy® for the Emergency Treatment of Allergic Reactions (Anaphylaxis)

    ALK-Abelló Pharmaceuticals Inc Announces Positive Funding Recommendation from Canada's Drug Agency for neffy® for the Emergency Treatment of Allergic Reactions (Anaphylaxis)
    CNW Group 30d ago
    Why ALK-Abelló (CPSE:ALK B) Is Getting Attention Today

    Why ALK-Abelló (CPSE:ALK B) Is Getting Attention Today
    Simply Wall St. 1mo ago
    Alk-Abello AS (AKBLF) (Q2 2026) Earnings Call Highlights: Strong Tablet Sales and Raised ...

    Alk-Abello AS (AKBLF) (Q2 2026) Earnings Call Highlights: Strong Tablet Sales and Raised ...
    GuruFocus.com 2mo ago
    Is It Too Late To Consider ALK-Abelló (CPSE:ALK B) After Strong Multi‑Year Gains?

    Is It Too Late To Consider ALK-Abelló (CPSE:ALK B) After Strong Multi‑Year Gains?
    Simply Wall St. 4mo ago
    Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff

    Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
    GlobeNewswire 6mo ago
    Alk-Abello AS (AKBLF) Q3 2025 Earnings Call Highlights: Robust Revenue and Earnings Growth Amid ...

    Alk-Abello AS (AKBLF) Q3 2025 Earnings Call Highlights: Robust Revenue and Earnings Growth Amid ...
    GuruFocus.com 11mo ago
    ALK to present at the Morgan Stanley Global Healthcare Conference in New York

    ALK to present at the Morgan Stanley Global Healthcare Conference in New York
    GlobeNewswire 1mo ago
    Assessing ALK Abelló (CPSE:ALK B) Valuation After Strong Recent Share Price Momentum

    Assessing ALK Abelló (CPSE:ALK B) Valuation After Strong Recent Share Price Momentum
    Simply Wall St. 5mo ago
    Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight

    Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
    PR Newswire 3mo ago
    Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy

    Phase 3 trial in China successfully confirms ACARIZAX® safety and efficacy in patients with house dust mite allergy
    GlobeNewswire 12d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: